Robin Swartz Appointed President of Voyager Therapeutics, Inc.
PUBLIC · VYGROct 21, 2026
Internal move“Her vast experience includes previous positions as Chief Operating Officer and Chief Business Officer at the company.”
Position
President
Company
Voyager Therapeutics
Robin Swartz
CambridgeBiotechnologyHealth CareTherapeutics
Description
On October 20, 2026, Voyager Therapeutics, Inc. appointed Robin Swartz as President, effective immediately. Swartz also is expected to succeed Alfred W
Who to call at Voyager Therapeutics, and when
A new leader at Voyager Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Voyager Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Voyager Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Voyager Therapeutics
Location
Cambridge, Massachusetts, United States
About
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Voyager Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyHealth CareTherapeutics